Downstream Processing in Biotechnology 2021
DOI: 10.1515/9783110574111-005
|View full text |Cite
|
Sign up to set email alerts
|

5 Electro-membrane separations in biotechnology

Abstract: Membrane processes are of crucial importance for downstream processing in biotechnology. This is due to their selectivity and the mild operating conditions, enabling to extract target products without damages caused by overheating and chemical agents. Besides the most spread membrane processes like ultrafiltration and reverse osmosis, electrodialysis is very important for removal and extraction of electrically charged products, i. e. anions of organic acids, some antibiotics, etc. The electrodialysis process c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Despite the high selectivity, high resolution and high purity of the product, chromatography also exhibits some limitations, namely low associated throughputs, low proteolytic and chemical stabilities when biological ligands are used, high scale pressure drops, time-consuming nature, and high costs, which hinder the production of biopharmaceuticals at low cost ( Rosa et al, 2010 ; Jozala et al, 2016 ; Castro et al, 2019 ; Castro et al, 2020 ). To surpass these limitations, research has focused on the development of chromatographic ligands with enhanced selectivity, robustness, and reproducibility ( Martins et al, 2014 ), as well as on non-chromatographic strategies, such as affinity precipitation ( Hoffman et al, 2001 ; Roque et al, 2007 ), preparative electrophoresis ( Thomas et al, 2002 ), high-performance tangential flow filtration ( Lazarova et al, 2001 ), membrane filtration ( Castilho et al, 2002 ), precipitation ( dos Santos et al, 2017 ), aqueous biphasic systems ( Zijlstra et al, 1998 ; Azevedo et al, 2009 ), non-chromatographic magnetic separation ( Karl and Schwa, 2005 ), high-gradient magnetic separation ( Akgo et al, 2004 ; Gomes et al, 2018 ), and crystallization ( dos Santos et al, 2017 ). Nevertheless, the progress made in this field is still far from that required, and downstream processing continues to account for the most expensive part of biomanufacturing ( Azevedo et al, 2009 ).…”
Section: Biopharmaceuticals Manufacturingmentioning
confidence: 99%
“…Despite the high selectivity, high resolution and high purity of the product, chromatography also exhibits some limitations, namely low associated throughputs, low proteolytic and chemical stabilities when biological ligands are used, high scale pressure drops, time-consuming nature, and high costs, which hinder the production of biopharmaceuticals at low cost ( Rosa et al, 2010 ; Jozala et al, 2016 ; Castro et al, 2019 ; Castro et al, 2020 ). To surpass these limitations, research has focused on the development of chromatographic ligands with enhanced selectivity, robustness, and reproducibility ( Martins et al, 2014 ), as well as on non-chromatographic strategies, such as affinity precipitation ( Hoffman et al, 2001 ; Roque et al, 2007 ), preparative electrophoresis ( Thomas et al, 2002 ), high-performance tangential flow filtration ( Lazarova et al, 2001 ), membrane filtration ( Castilho et al, 2002 ), precipitation ( dos Santos et al, 2017 ), aqueous biphasic systems ( Zijlstra et al, 1998 ; Azevedo et al, 2009 ), non-chromatographic magnetic separation ( Karl and Schwa, 2005 ), high-gradient magnetic separation ( Akgo et al, 2004 ; Gomes et al, 2018 ), and crystallization ( dos Santos et al, 2017 ). Nevertheless, the progress made in this field is still far from that required, and downstream processing continues to account for the most expensive part of biomanufacturing ( Azevedo et al, 2009 ).…”
Section: Biopharmaceuticals Manufacturingmentioning
confidence: 99%